Genome Research Papers on Early SARS-CoV-2 Circulation in NYC, Drug Response Assay, More

Nov 18, 2020

SARS-CoV-2 circulated under the radar in the New York City area for a "prolonged period," according to a viral genome sequencing analysis led by investigators at the New York University Grossman School of Medicine. The researchers considered SARS-CoV-2 sequence data, infected individuals' travel or exposure histories, and other factors, focusing on 864 cases diagnosed in the NYC metro area this spring.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Vaccine Authorization

The UK has given emergency authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine, the Associated Press reports.

Healthcare Workers, Nursing Home Residents First

A US advisory committee says healthcare workers and nursing home residents should be prioritized to receive a SARS-CoV-2 vaccine, according to the Financial Times.

Hackers Target Vaccine Makers

The Wall Street Journal reports North Korean hackers have targeted half a dozen companies developing SARS-CoV-2 vaccines.

Cell Studies on Months-Long SARS-CoV-2 Shedding, Spike Mutation, Ebola Infection Dynamics

In Cell this week: long-term SARS-CoV-2 shedding, examination of the effects of a coronavirus spike protein mutation, and more.

Menu